Support emerging or mature Biotech/Pharma companies with expertise in Supply Chain risk profiling and CMO relationship management

Supported all supply chain activities associated with their late-stage development programs of rhAC Enzyme and Sodium Fusidate

Supported all supply chain activities associated with their sustained release development program for wAMD (ALTISSIMO Trial)Forged strong relationships with strategic CMO's for drug product and clinical packaging

Position Eliminated due to Phase III Clinical Trial results not meeting expected outcomes

Developed Key relationships with our strategic CMO's for Drug Substance, Drug Product and Key SM'sSupported the successful validation activities of the technical team for Drug Substance and Drug ProductEvaluated Risks associated with the planned launch strategy including 2nd sourcing activitiesDeveloped a Planning and scheduling model to support internal resource requirements and key metrics with our CMO's

Managed a direct report team of 4 professionals with responsibiity for 100mm if Direct Spend, 10mm of Indirect Spend (MRO/Consumables) and $15mm of Capital Spend AnnuallySuccessfully implmented spending controls and achieved > $2mm in annual savings over the last 5 yearsKeys area of responsibility: Product Launch Coordination Sourcing of Direct and Indirect Materials including Capital Equipment Master Planning ERP Shop Floor Scheduling CMO Management of Critical Vendors Warehousing and Distribution Management Management of materials for > 20 active R&D Projects Key Supply Chain Successess Manage a Commercial Product Portfolio of > 100 SKU's with 99.5% stocking rates Successful Product Launches of Omeprazole, Nifedipine, Venlafaxine, Pantoprazole, Rabeprazole Glycolax OTC/ Rx, Methylphenidate, Atorvastatin and Montelukast Sodium Direct involvement in the site transferof over 30 products with no Stock Outages Keys to Supply Success Strong Financial Skills - Balancing Service Levels with Asset Optimization (Total Cost of Ownership) Relationships Matter both internal and external for sustainable success Support the team encouraging "End to End Ownership" and not just acquisition of materials Committment to strategic change as an opportunity to challenge the "Status Quo"